Primary Myoclonus-Dystonia: A Diagnosis Often Missed in Children

Area of Science:

• Pediatric Neurology
• Genetics
• Movement Disorders

Background:

• Primary myoclonus-dystonia is a rare, inherited movement disorder affecting children.
• Characterized by involuntary muscle jerks (myoclonus) and sustained muscle contractions (dystonia).
• Often misdiagnosed, leading to delayed treatment and increased patient burden.

Purpose of the Study:

• To report on a cohort of children diagnosed with primary myoclonus-dystonia.
• To highlight diagnostic challenges and delays in pediatric neurology.
• To emphasize the genetic basis and potential treatment responses.

Main Methods:

• Retrospective case series of 9 children with myoclonus-dystonia over 4 years.
• Clinical evaluation, genetic analysis of the ε-sarcoglycan (SGCE) gene.
• Review of diagnostic pathways and treatment outcomes.

Main Results:

• Mean age of symptom onset was 2.8 years, with a mean diagnostic age of 7.3 years.
• Myoclonus was the initial symptom in 8 out of 9 children.
• Pathogenic mutations in the SGCE gene were found in 6 children (2 novel).
• Positive response to medications like trihexyphenidyl and clonazepam.
• Two patients benefited from deep brain stimulation.
• Diagnostic delays occurred in 7 children due to lack of consideration by referring neurologists.

Conclusions:

• Primary myoclonus-dystonia requires greater awareness among child neurologists for timely diagnosis.
• Genetic testing for SGCE mutations is important for affected children.
• Pharmacological and surgical interventions can be effective management options.